Nicotine Receptors and COX2 in the Aging Brain
衰老大脑中的尼古丁受体和 COX2
基本信息
- 批准号:8021012
- 负责人:
- 金额:$ 23.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-05-01 至 2013-01-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAgeAgingAgonistAnimalsAnti-Inflammatory AgentsAnti-inflammatoryAstrocytesBiological ModelsBrainCongenic MiceDissectionElderlyEquilibriumGene ExpressionGeneticHippocampus (Brain)InflammationInflammation MediatorsInflammatoryInterneuron functionInterneuronsInterventionMeasuresMetabolicMouse StrainsNeuronsNicotineNicotinic ReceptorsNon-Steroidal Anti-Inflammatory AgentsOutcomePPAR gammaPPARgamma2PTGS2 geneParvalbuminsPhenotypePlayPredispositionProcessRXRReceptor CellRegulationRelative (related person)Research PersonnelRoleSeveritiesSignal PathwaySomatostatinSystemTherapeuticTherapeutic InterventionWorkage relatedagedaging braincholinergiccyclooxygenase 2microchipnovelprogramsreceptorreceptor expressionreceptor functionresponsetherapeutic targettissue culturetranscription factor
项目摘要
DESCRIPTION (provided by applicant): Aging of the mammalian brain is accompanied by reduced expression of neuronal nicotinic acetylcholine receptors (nAChR), and decreased control of pro-inflammatory mechanisms. Our previous findings identified age-related and mouse strain-specific changes in nAChR expression by hippocampal interneurons (and astrocytes) and identified interactions with either the inflammatory mediator cyclooxygenase 2 (Cox2), or the RXR co-transcription factor, PPARgamma. We will now focus on genetic and cellular mechanisms contributing to these interactions. Completion of these studies will identify genetic mechanisms and possible therapeutic strategies for interventions that will promote stability of nAChR expression into advanced age. SPECIFIC AIM 1. Hypothesis: Interneuron subtypes, as defined by differential nAChR, somatostatin and Cox2/PPARgamma2 expression, vary in their relative susceptibility to age-related decline. Differential nAChR expression defines at least 4 interneuron subclasses in hippocampal CA1, but there are additional subtypes whose relative susceptibility to age-related loss will be determined. SPECIFIC AIM 2. Hypothesis: Intracellular pathways that signal neuronal responses to either nicotine or NSAIDs contribute to regulating nAChR expression in the aged brain, but converge to become antagonistic. Long-term NSAID administration promotes retention of nAChR expression into old age, but this is antagonized by co-administration of nicotine. A primary neuronal tissue culture model system will be used to define intracellular signaling pathways where these agents converge to produce antagonism. SPECIFIC AIM 3. Hypothesis: The efficacy of long-term administration of nicotine, Cox2 antagonists, and/or PPARgamma agonists on retaining nAChRalpha4 expression in aged animals is determined by strain-specific genetic background. Using newly generated congenic mouse lines, the importance of nAChR expression by astrocytes versus other components of the genetic background will be measured to identify strain-specific components of the nicotine and NSAID interaction, and determine if NSAIDs, working as PPARgamma agonists, promote retention of nAChRalpha4 expression in the aging brain.
描述(由申请人提供):哺乳动物大脑的衰老伴随着神经元烟碱乙酰胆碱受体(NACHR)的表达降低,以及对促炎机制的控制降低。我们以前的发现确定了海马中神经元(和星形胶质细胞)中与年龄相关的NACHR表达中与小鼠菌株特异性的变化,并鉴定了与炎性介导剂环氧酶2(COX2)或RXR共同转录因子Ppargamma的相互作用。现在,我们将重点关注导致这些相互作用的遗传和细胞机制。这些研究的完成将确定遗传机制和干预措施的可能治疗策略,以促进NACHR表达在高级年龄中的稳定性。具体目标1。假设:中间的亚型,如差异NACHR,生长抑素和Cox2/ppargamma2的表达所定义,其相对易感性与年龄相关下降的敏感性有所不同。差异NACHR表达在海马CA1中定义了至少4个中间元亚类,但是还有其他亚型的相对易感性将确定与年龄相关的损失的相对敏感性。特定目的2。假设:信号对尼古丁或NSAID的神经元反应的细胞内途径有助于调节老年大脑中的NACHR表达,但会融合以拮抗。长期的NSAID给药促进了NACHR表达在老年中的保留,但这是通过尼古丁的共同给药来拮抗的。原发性神经组织培养模型系统将用于定义细胞内信号传导途径,在这些途径中,这些药物会融合产生拮抗作用。特定目的3。假设:尼古丁,COX2拮抗剂和/或ppargamma激动剂在衰老动物中保留nachralpha4表达的疗效取决于菌株特异性的遗传背景。使用新生成的异基因小鼠系,将测量星形胶质细胞与遗传背景的其他成分的NACHR表达的重要性,以鉴定尼古丁和NSAID相互作用的菌株特异性成分,并确定NSAID是否作为ppargamma激动剂起作用,促进鼻中pha44在脂肪脑中的静止。
项目成果
期刊论文数量(15)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nicotinic receptor Alpha7 expression during tooth morphogenesis reveals functional pleiotropy.
牙齿形态发生过程中烟碱受体 Alpha7 的表达揭示了功能多效性。
- DOI:10.1371/journal.pone.0036467
- 发表时间:2012
- 期刊:
- 影响因子:3.7
- 作者:Rogers,ScottW;Gahring,LoriseC
- 通讯作者:Gahring,LoriseC
Nicotinic receptor alpha7 expression identifies a novel hematopoietic progenitor lineage.
- DOI:10.1371/journal.pone.0057481
- 发表时间:2013
- 期刊:
- 影响因子:3.7
- 作者:Gahring LC;Enioutina EY;Myers EJ;Spangrude GJ;Efimova OV;Kelley TW;Tvrdik P;Capecchi MR;Rogers SW
- 通讯作者:Rogers SW
Prenatal ablation of nicotinic receptor alpha7 cell lineages produces lumbosacral spina bifida the severity of which is modified by choline and nicotine exposure.
- DOI:10.1002/ajmg.a.35372
- 发表时间:2012-05
- 期刊:
- 影响因子:2
- 作者:Rogers, Scott W.;Tvrdik, Petr;Capecchi, Mario R.;Gahring, Lorise C.
- 通讯作者:Gahring, Lorise C.
Neuronal nicotinic alpha7 receptors modulate early neutrophil infiltration to sites of skin inflammation.
- DOI:10.1186/1742-2094-7-38
- 发表时间:2010-07-12
- 期刊:
- 影响因子:9.3
- 作者:Gahring LC;Osborne AV;Reed M;Rogers SW
- 通讯作者:Rogers SW
Nicotinic receptor subunit alpha5 modifies assembly, up-regulation, and response to pro-inflammatory cytokines.
烟碱受体亚基 α5 修饰组装、上调以及对促炎细胞因子的反应。
- DOI:10.1074/jbc.m110.105346
- 发表时间:2010
- 期刊:
- 影响因子:0
- 作者:Gahring,LoriseC;Rogers,ScottW
- 通讯作者:Rogers,ScottW
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SCOTT Warren ROGERS其他文献
SCOTT Warren ROGERS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SCOTT Warren ROGERS', 18)}}的其他基金
Nicotinic Receptors and COX2 in the Aging Brain
衰老大脑中的烟碱受体和 COX2
- 批准号:
6509696 - 财政年份:2001
- 资助金额:
$ 23.42万 - 项目类别:
Nicotine Receptors and COX2 in the Aging Brain
衰老大脑中的尼古丁受体和 COX2
- 批准号:
7569455 - 财政年份:2001
- 资助金额:
$ 23.42万 - 项目类别:
Nicotinic Receptors and COX2 in the Aging Brain
衰老大脑中的烟碱受体和 COX2
- 批准号:
6326425 - 财政年份:2001
- 资助金额:
$ 23.42万 - 项目类别:
Nicotine Receptors and COX2 in the Aging Brain
衰老大脑中的尼古丁受体和 COX2
- 批准号:
7339627 - 财政年份:2001
- 资助金额:
$ 23.42万 - 项目类别:
Nicotine Receptors and COX2 in the Aging Brain
衰老大脑中的尼古丁受体和 COX2
- 批准号:
7196363 - 财政年份:2001
- 资助金额:
$ 23.42万 - 项目类别:
Nicotinic Receptors and COX2 in the Aging Brain
衰老大脑中的烟碱受体和 COX2
- 批准号:
6629863 - 财政年份:2001
- 资助金额:
$ 23.42万 - 项目类别:
Nicotine Receptors and COX2 in the Aging Brain
衰老大脑中的尼古丁受体和 COX2
- 批准号:
7793471 - 财政年份:2001
- 资助金额:
$ 23.42万 - 项目类别:
CNS Disease and Autoimmunity of Glutamate Receptors
中枢神经系统疾病与谷氨酸受体自身免疫
- 批准号:
6621320 - 财政年份:1997
- 资助金额:
$ 23.42万 - 项目类别:
CNS DISEASE AND AUTOIMMUNITY TO GLUTAMATE RECEPTORS
中枢神经系统疾病与谷氨酸受体自身免疫
- 批准号:
2038291 - 财政年份:1997
- 资助金额:
$ 23.42万 - 项目类别:
相似国自然基金
TBX20在致盲性老化相关疾病年龄相关性黄斑变性中的作用和机制研究
- 批准号:82220108016
- 批准年份:2022
- 资助金额:252 万元
- 项目类别:国际(地区)合作与交流项目
LncRNA ALB调控LC3B活化及自噬在体外再生晶状体老化及年龄相关性白内障发病中的作用及机制研究
- 批准号:81800806
- 批准年份:2018
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
APE1调控晶状体上皮细胞老化在年龄相关性白内障发病中的作用及机制研究
- 批准号:81700824
- 批准年份:2017
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
KDM4A调控平滑肌细胞自噬在年龄相关性血管老化中的作用及机制
- 批准号:81670269
- 批准年份:2016
- 资助金额:55.0 万元
- 项目类别:面上项目
老年人一体化编码的认知神经机制探索与干预研究:一种减少与老化相关的联结记忆缺陷的新途径
- 批准号:31470998
- 批准年份:2014
- 资助金额:87.0 万元
- 项目类别:面上项目
相似海外基金
The Influence of Lifetime Occupational Experience on Cognitive Trajectories Among Mexican Older Adults
终生职业经历对墨西哥老年人认知轨迹的影响
- 批准号:
10748606 - 财政年份:2024
- 资助金额:
$ 23.42万 - 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 23.42万 - 项目类别:
Understanding the Mechanisms and Consequences of Basement Membrane Aging in Vivo
了解体内基底膜老化的机制和后果
- 批准号:
10465010 - 财政年份:2023
- 资助金额:
$ 23.42万 - 项目类别:
Maternal inflammation in relation to offspring epigenetic aging and neurodevelopment
与后代表观遗传衰老和神经发育相关的母体炎症
- 批准号:
10637981 - 财政年份:2023
- 资助金额:
$ 23.42万 - 项目类别: